News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Biller Scott
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/22/2022 |
4
| Biller Scott (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.81, valued at
$221k
|
|
| 07/14/2021 |
4
| Biller Scott (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 12,530 options to buy
@ $9.4, valued at
$117.8k
|
|
| 10/22/2020 |
3
| Biller Scott (Director) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 06/13/2019 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 7,218 options to buy
@ $2.3375, valued at
$16.9k
|
|
| 04/09/2019 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,401 shares
@ $67.61, valued at
$162.3k
Sold 599 shares
@ $68.12, valued at
$40.8k
Exercised 3,000 options to buy
@ $39.76, valued at
$119.3k
|
|
| 03/07/2019 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 200 shares
@ $66.45, valued at
$13.3k
Sold 2,600 shares
@ $67.73, valued at
$176.1k
Sold 200 shares
@ $68.22, valued at
$13.6k
Exercised 428 options to buy
@ $31.64, valued at
$13.5k
Exercised 2,572 options to buy
@ $39.76, valued at
$102.3k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 20,500 options to buy
@ $2.3375, valued at
$47.9k
|
|
| 11/07/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,200 shares
@ $69.44, valued at
$152.8k
Sold 700 shares
@ $70.23, valued at
$49.2k
Sold 100 shares
@ $71.42, valued at
$7.1k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 640 shares
@ $82.52, valued at
$52.8k
Sold 2,260 shares
@ $83.17, valued at
$188k
Sold 100 shares
@ $84.38, valued at
$8.4k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 08/10/2018 |
4/A
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 08/10/2018 |
4/A
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 08/10/2018 |
4/A
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 15,177 options to buy
@ $31.64, valued at
$480.2k
|
|
| 08/10/2018 |
4/A
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 08/10/2018 |
4/A
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 08/10/2018 |
4/A
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 37 options to buy
@ $0.4675, valued at
$17.3
Exercised 4,100 options to buy
@ $2.34, valued at
$9.6k
|
|
| 08/08/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 300 shares
@ $78.32, valued at
$23.5k
Sold 2,100 shares
@ $80.15, valued at
$168.3k
Sold 600 shares
@ $80.87, valued at
$48.5k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 07/09/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 2,700 shares
@ $83.41, valued at
$225.2k
Sold 300 shares
@ $84.32, valued at
$25.3k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 06/07/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 802 shares
@ $92.45, valued at
$74.1k
Sold 1,259 shares
@ $93.27, valued at
$117.4k
Sold 939 shares
@ $94.28, valued at
$88.5k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 05/29/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 15,177 shares
@ $90, valued at
$1.4M
Exercised 15,177 options to buy
@ $31.64, valued at
$480.2k
|
|
| 05/08/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 3,000 shares
@ $81.81, valued at
$245.4k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 04/09/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 1,300 shares
@ $73.9, valued at
$96.1k
Sold 400 shares
@ $75.04, valued at
$30k
Sold 800 shares
@ $76.17, valued at
$60.9k
Sold 500 shares
@ $77.17, valued at
$38.6k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 03/30/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 37 options to buy
@ $0.4675, valued at
$17.3
Exercised 4,100 options to buy
@ $2.34, valued at
$9.6k
|
|
| 03/07/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 400 shares
@ $80.93, valued at
$32.4k
Sold 400 shares
@ $82.04, valued at
$32.8k
Sold 1,100 shares
@ $83.21, valued at
$91.5k
Sold 1,100 shares
@ $84.1, valued at
$92.5k
Exercised 3,000 options to buy
@ $9.05, valued at
$27.2k
|
|
| 02/20/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 33,000 options to buy
@ $77.7, valued at
$2.6M
Granted 8,250 restricted stock units
@ $0 |
|
| 02/07/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 799 shares
@ $74.89, valued at
$59.8k
Sold 1,100 shares
@ $75.7, valued at
$83.3k
Sold 701 shares
@ $76.76, valued at
$53.8k
Sold 400 shares
@ $78.03, valued at
$31.2k
Exercised 64 options to buy
@ $0.4675, valued at
$29.9
Exercised 2,936 options to buy
@ $9.05, valued at
$26.6k
|
|
| 01/12/2018 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 3,000 shares
@ $65, valued at
$195k
Exercised 3,000 options to buy
@ $0.4675, valued at
$1.4k
|
|
| 12/08/2017 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Exercised 14,875 options to buy
@ $0.4675, valued at
$7k
Exercised 102 options to buy
@ $0.4675, valued at
$47.7
Exercised 31,818 options to buy
@ $2.3375, valued at
$74.4k
|
|
| 12/05/2017 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 600 shares
@ $59.89, valued at
$35.9k
Sold 846 shares
@ $60.63, valued at
$51.3k
Sold 700 shares
@ $61.76, valued at
$43.2k
Exercised 2,146 options to buy
@ $31.64, valued at
$67.9k
|
|
| 11/03/2017 |
4
| Biller Scott (Chief Scientific Officer) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Sold 100 shares
@ $65.45, valued at
$6.5k
Sold 200 shares
@ $63.62, valued at
$12.7k
Sold 900 shares
@ $63.09, valued at
$56.8k
Sold 946 shares
@ $61.81, valued at
$58.5k
Exercised 2,146 options to buy
@ $31.64, valued at
$67.9k
|
|
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|